ScoreWhy is Marksans Pharma Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 5.08% of over the last 5 years
2
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 04-Apr-25 and has generated -1.47% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
With ROE of 15.2, it has a Expensive valuation with a 3.9 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 24.32%, its profits have risen by 16.1% ; the PEG ratio of the company is 1.5
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Marksans Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Marksans Pharma
24.38%
0.44
55.85%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.01%
EBIT Growth (5y)
5.08%
EBIT to Interest (avg)
35.46
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.27
Tax Ratio
24.30%
Dividend Payout Ratio
8.67%
Pledged Shares
0
Institutional Holding
26.26%
ROCE (avg)
35.84%
ROE (avg)
18.70%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
33
Price to Book Value
3.86
EV to EBIT
19.36
EV to EBITDA
16.27
EV to Capital Employed
4.61
EV to Sales
3.37
PEG Ratio
1.49
Dividend Yield
0.31%
ROCE (Latest)
23.44%
ROE (Latest)
15.21%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
NET SALES(Q)
Highest at Rs 681.85 cr
PBDIT(Q)
Highest at Rs 138.77 cr.
PBT LESS OI(Q)
Highest at Rs 115.41 cr.
PAT(Q)
At Rs 104.56 cr has Grown at 20.5% (vs previous 4Q average
EPS(Q)
Highest at Rs 2.31
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Marksans Pharma
Net Sales - Quarterly
Highest at Rs 681.85 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 138.77 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 115.41 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 104.56 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 104.56 cr has Grown at 20.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 86.75 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.31
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Marksans Pharma
Non Operating Income - Quarterly
Highest at Rs 27.85 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
